VRDN R&D to Revenue
Viridian Therapeutics Ors Inc · R&D to Revenue
VRDN R&D to Revenue
Latest reported478.38%period ending
VRDN FY R&D/Revenue (5.12% → 478.38%)
Latest values, visible window
High-resolution chart · PNG
VRDN r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 478.3822% | |
| 78,892.053% | |
| 50,880.5732% | |
| 5,693.7923% | |
| 1,919.8785% | |
| 2,695.619% | |
| 779.9597% | |
| 362.7594% | |
| 490.2073% | |
| 26.6107% | |
| 39.4799% | |
| 6.7824% | |
| 2.2437% | |
| 5.1152% |